Patent classifications
C07C219/24
Aminoadamantyl nitrate compounds and their use to treat CNS disorders
The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.
NOVEL COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
A novel compound for a capping layer, and an organic light emitting device containing the same are disclosed. The compound for a capping layer is represented by Formula 1 below:
##STR00001##
Resist composition and patterning process
A resist composition comprising a base polymer and a sulfonium salt of amino-containing carboxylic acid offers dimensional stability on PPD and a satisfactory resolution.
Resist composition and patterning process
A resist composition comprising a base polymer and a sulfonium salt of amino-containing carboxylic acid offers dimensional stability on PPD and a satisfactory resolution.
Compounds and compositions for treating HIV with derivatives of Betulin
The present invention relates to compounds characterized by having a structure according to the following Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
Compounds and compositions for treating HIV with derivatives of Betulin
The present invention relates to compounds characterized by having a structure according to the following Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((4S, 2S, 4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity.
PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS
The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((4S, 2S, 4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity.
DERIVATIVES OF BETULIN
The present invention relates to compounds characterized by having a structure according to the following Formula I:
##STR00001##
, or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
DERIVATIVES OF BETULIN
The present invention relates to compounds characterized by having a structure according to the following Formula I:
##STR00001##
, or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.